The risk for an unfavourable course of SARS-CoV-2 pneumonia rises with age and comorbidities. We report the case of an elderly female where the sum of such factors - together with massive findings in the computed tomography of the lung - led us to a therapy with hydroxychloroquine as a compassionate use. The unfavourable outcome demonstrates that - despite the enthusiasm of some authors - hydroxychloroquine is no miracle drug. The worldwide SOLIDARITY trial will help clinicians to assess the potential of the repurposed antimalarial drugs better.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
hydroxychloroquine miracle
8
elderly female
8
miracle cure
4
cure covid-19
4
covid-19 infection
4
infection -imaging
4
-imaging clinical
4
clinical course
4
course elderly
4
female risk
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!